Neurological soft signs in schizophrenic patients and their nonpsychotic siblings

Schizophrenia Research

Volumn 58, Issue 2-3, 2002, Pages 241-246

  Yazici, Ali H ^a   Demir, Başaran ^a   Yazici, Kâzim M ^a   Gö̌üş, Ahmet ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Neurology; Schizophrenia

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENVIRONMENT; FEMALE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PATHOGENESIS; POSITIVE SYNDROME; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRY; SCHIZOPHRENIA; SIBLING;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSERVER VARIATION; PERCEPTUAL DISORDERS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR DISORDERS; SCHIZOPHRENIA; SIBLINGS;

EID: 0036888333     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00338-3     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 4th edn. 1994;American Psychiatric Association, Washington, DC.
2. Arango C., Bartko J.J., Gold J.M.et al. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am. J. Psychiatry. 156:1999;1349-1357.
3. Buchanan R.W., Heinrichs D.W. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 27:1989;335-350.
4. Cannon T.D., Zorilla L.E., Shtasel D.et al. Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Arch. Gen. Psychiatry. 51:1994;651-661.
5. Cantor-Graae E., McNeil T.F., Rickler K.C.et al. Are neurological abnormalities in well discordant monozygotic co-twins of schizophrenic subjects the result of perinatal trauma? Am. J. Psychiatry. 151:1994;1194-1199.
6. Chen E.Y., Lam L.C.W., Chen R.Y.et al. Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. Br. J. Psychiatry. 168:1996;227-233.
7. Chen E.Y., Kwok C.L., Au J.W.et al. Progressive deterioration of soft neurological signs in chronic schizophrenic patients. Acta Psychiatr. Scand. 102:2000;342-349.
8. Chen Y.L., Chen Y.H., Mak F.L. Soft neurological signs in schizophrenic patients and their nonpscyhotic siblings. J. Nerv. Ment. Dis. 188:2000;284-289.
9. Erlenmeyer-Kimling X., Golden R., Cornblatt B. A taxometric analysis of cognitive and neuromotor variables in children at risk for schizophrenia. J. Abnorm. Psychol. 98:1989;203-208.
10. Flashman L.A., Flaum M., Gupta S.et al. Soft signs and neuropsychological performance in schizophrenia. Am. J. Psychiatry. 153:1996;526-532.
11. Flyckt L., Sydow O., Bjerkenstedt L.et al. Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls. Psychiatry Res. 86:1999;113-119.
12. Gupta S., Andreasen N.C., Arndt S.et al. Neurological soft signs in neuroleptic-naive and neuroleptic treated schizophrenic patients and in normal comparison subjects. Am. J. Psychiatry. 152:1995;191-196.
13. Heinrichs D.W., Buchanan R.W. The significance and meaning of neurological signs in schizophrenia. Am. J. Psychiatry. 145:1988;11-18.
14. Ismail B., Cantor-Graae E., McNeil T.F. Neurological abnormalities in schizophrenic patients and their siblings. Am. J. Psychiatry. 155:1998;84-89.
15. Kay S., Fiszbein A., Opler L. The positive and negative syndrome scale for schizophrenia (PANSS). Schizophr. Bull. 13:1987;261-276.
16. Kinney D.K., Yergelun-Todd D.A., Woods B.T. Hard neurologic signs and psychopathology in relatives of schizophrenic patients. Psychiatry Res. 39:1991;45-53.
17. Kostakoglu E., Batur S., Tiryaki A.et al. Reliability and validity of the Turkish version of the Positive and Negative Syndrome Scale. Turk. J. Psychol. 44:1999;33-34.
18. Lane A., Colgan K., Moynihan F.et al. Schizophrenia and neurological soft signs: gender differences in clinical correlates and antecedent factors. Psychiatry Res. 64:1996;105-114.
19. Marcus J., Hans S.L., Lewow E.et al. Neurological findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr. Bull. 11:1985;85-100.
20. McNeil T.F., Cantor-Grae E., Torrey E.F.et al. Obstetric complications in histories of monozygotic twins discordant and concordant for schizophrenia. Acta Psychiatr. Scand. 89:1994;196-204.
21. Merriam A.E., Kay S.R., Opler L.A.et al. Neurological signs and positive-negative dimension in schizophrenia. Biol. Psychiatry. 28:1990;181-192.
22. Mohr F., Hubmann W., Cohen R.et al. Neurological soft signs in schizophrenia: assessment and correlates. Eur. Arch. Psychiatry Clin. Neurosci. 246:1996;240-248.
23. Owens D.G.C., Johnstone E.C. The disabilities of chronic schizophrenia - their nature and the factors contributing to their development. Br. J. Psychiatry. 136:1980;384-395.
24. Pearlson G., Garbacz D., Breakey W.et al. Lateral ventricular enlargement associated with persistent unemployment and negative symptoms in both schizophrenia and bipolar disorder. Psychiatry Res. 12:1984;1-9.
25. Rubin P., Vorstrup S., Hemmingsen R.et al. Neurological abnormalities in patients with schizophrenia or schizophreniform disorder at first admission to hospital: correlations with computerized tomography and regional cerebral blood flow findings. Acta Psychiatr. Scand. 90:1994;385-390.
26. Simpson G.M., Angus J.W.S. A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand. 212:1970;11-19. (Suppl.).
27. Torrey E.F. Neurological abnormalities in schizophrenic patients. Biol. Psychiatry. 15:1980;381-388.
28. Wong A.H.C., Voruganti L.N.P., Heslegrave R.J.et al. Neurocognitive deficits and neurological signs in schizophrenia. Schizophr. Res. 23:1997;139-146.
29. Woods B.T., Kinney D.K., Yergelun-Todd D. Neurologic abnormalities in schizophrenic patients and their families. Arch. Gen. Psychiatry. 43:1986;657-663.
30. World Health Organization Schedules for Clinical Assessment in Neuropsychiatry. 1992;World Health Organization, Geneva, Switzerland.